Phase Ib study of ipilimumab alone or in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene (vaccine) in pancreatic cancer.

Authors

Dung Le

Dung Thi Le

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD

Dung Thi Le , Eric Lutz , Lanqing Huang , Beth Onners , Jennifer Uram , Sara Solt , Elizabeth Sugar , Lei Zheng , Elizabeth M. Jaffee , Dan Laheru

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT00836407

Citation

J Clin Oncol 30, 2012 (suppl 4; abstr 211)

DOI

10.1200/jco.2012.30.4_suppl.211

Abstract #

211

Poster Bd #

B19

Abstract Disclosures

Similar Posters

First Author: Espen Basmo Ellingsen

Poster

2018 ASCO-SITC Clinical Immuno-Oncology Symposium

Systemic immune signature of inflammation in metastatic melanoma (MM) patients treated with ipilimumab (IPI) and carboplatin/paclitaxel (CP).

Systemic immune signature of inflammation in metastatic melanoma (MM) patients treated with ipilimumab (IPI) and carboplatin/paclitaxel (CP).

First Author: Wilson H. Miller

First Author: Sofie Kirial Mørk